Results for this period
First quarter1 March 2026–31 May 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
The shaded area represents net assets as a proportion of total assets. It is calculated from the two amounts reported by the company.
Net sales increased due to firm orders from domestic and overseas cosmetics manufacturers and the recovery in orders for pharmaceuticals and cosmetics at the consolidated French subsidiary. Rising raw material costs, various expenses and labor costs weighed on earnings, but the recovery in the French consolidated subsidiary's performance resulting from the recovery in orders contributed to earnings.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 March 2026–31 May 2026 |
| Net Sales | ¥4,517,821 thousand (YoY +13.6%) |
| Operating profit | ¥107,334 thousand (YoY +24.3%) |
| Ordinary income | ¥78,888 thousand (YoY +3.8%) |
| Profit attributable to owners of the parent | ¥51,270 thousand (YoY +1.1%) |
| Total assets | ¥18,050,635 thousand |
| Net assets | ¥4,194,916 thousand |
| Full-year earnings forecast | Net Sales Not disclosed / Operating profit Not disclosed / Ordinary income Not disclosed / Net income Not disclosed / Remarks Unchanged from the forecast announced on 13 April 2026 |
| Revision to Earnings Forecast | None (no change) |
| Segment revenue | Japan ¥3,154,649 thousand (YoY +8.8%), France ¥1,467,199 thousand (YoY +33.4%) |
| Segment profit | Japan ¥113,899 thousand (YoY -25.5%), France ¥2,411 thousand |
| Regional sales | ¥3,154,649 thousand (YoY +8.8%), ¥1,467,199 thousand (YoY +33.4%) |
| Depreciation and amortization | ¥234,542 thousand |
| Impairment loss | None (impairment loss on fixed assets) |
| Breakdown of extraordinary income (loss) | Gain on sale of non-current assets ¥15 thousand, Loss on Disposal of Fixed Assets ¥532 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Factors Behind Changes in Business Performance | Net sales increased due to firm orders from domestic and overseas cosmetics manufacturers and the recovery in orders for pharmaceuticals and cosmetics at the consolidated French subsidiary. Rising raw material costs, various expenses and labor costs weighed on earnings, but the recovery in the French consolidated subsidiary's performance resulting from the recovery in orders contributed to earnings. |
Items this document does not state (18)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In addition to firm orders from domestic and overseas cosmetics manufacturers, orders for pharmaceuticals and cosmetics at the consolidated French subsidiary recovered. Meanwhile, higher raw material costs, various expenses, subcontract processing costs and labor costs weighed on earnings.